Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CymaBay Therapeutics, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $2.94 | Mar 22, 2024 | Direct |
CymaBay Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 0 | Mar 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CBAY | CymaBay Therapeutics, Inc. | Mar 22, 2024 | 3 | $0 | 4 | Mar 22, 2024 | Chief Financial Officer |
CBAY | CymaBay Therapeutics, Inc. | Jan 24, 2024 | 2 | $0 | 4 | Jan 26, 2024 | Chief Financial Officer |
CBAY | CymaBay Therapeutics, Inc. | May 22, 2023 | 1 | $0 | 4 | May 22, 2023 | Chief Financial Officer |
CBAY | CymaBay Therapeutics, Inc. | May 22, 2023 | 0 | $0 | 3 | May 22, 2023 | Chief Financial Officer |